Variant report
Variant | esv3326106 |
---|---|
Chromosome Location | chr1:217270420-217271648 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:217262623..217264529-chr1:217271593..217273634,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000196482 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs578236336 | chr1:217270421-217270422 | Strong transcription Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs538302835 | chr1:217270424-217270425 | Strong transcription Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs143864893 | chr1:217270439-217270440 | Strong transcription Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs557438233 | chr1:217270473-217270474 | Strong transcription Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs12034683 | chr1:217270475-217270476 | Strong transcription Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs543030375 | chr1:217270479-217270480 | Strong transcription Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs146853944 | chr1:217270480-217270481 | Strong transcription Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs527568408 | chr1:217270524-217270525 | Strong transcription Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs540956813 | chr1:217270527-217270528 | Strong transcription Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs375122994 | chr1:217270558-217270559 | Strong transcription Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs551750803 | chr1:217270599-217270600 | Strong transcription Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs201604665 | chr1:217270632-217270633 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs567394611 | chr1:217270633-217270634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs12756259 | chr1:217270643-217270644 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs830307 | chr1:217270667-217270668 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs569753138 | chr1:217270690-217270691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs528847483 | chr1:217270715-217270716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs12137803 | chr1:217270757-217270758 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs12126987 | chr1:217270794-217270795 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs535331943 | chr1:217270796-217270797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs558528305 | chr1:217270852-217270853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs114976420 | chr1:217270855-217270856 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs140638575 | chr1:217270900-217270901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs75484482 | chr1:217270914-217270915 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs574096973 | chr1:217270985-217270986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs144304518 | chr1:217271038-217271039 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs79689922 | chr1:217271078-217271079 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs200005529 | chr1:217271112-217271113 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs35118047 | chr1:217271113-217271114 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs386639381 | chr1:217271114-217271115 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs201118041 | chr1:217271115-217271116 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs564039430 | chr1:217271132-217271133 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs181689689 | chr1:217271149-217271150 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs185065959 | chr1:217271168-217271169 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs368950995 | chr1:217271185-217271186 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs5780964 | chr1:217271186-217271187 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs34051845 | chr1:217271202-217271203 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs189479224 | chr1:217271250-217271251 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs563478810 | chr1:217271266-217271267 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs181027472 | chr1:217271270-217271271 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs576363348 | chr1:217271283-217271284 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs545452324 | chr1:217271315-217271316 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs563369407 | chr1:217271338-217271339 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs145242544 | chr1:217271362-217271363 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs11808948 | chr1:217271374-217271375 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs830313 | chr1:217271395-217271396 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs549144280 | chr1:217271398-217271399 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs565669434 | chr1:217271448-217271449 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs528101730 | chr1:217271459-217271460 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs61816747 | chr1:217271481-217271482 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Liposarcoma | 21253554 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
Multiple myeloma | 16461302 | CNVD |
van der Woude syndrome | 22470819 | CNVD |
van der Woude syndrome | 20818247 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21720365 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Holoprosencephaly | 19184110 | CNVD |
Breast cancer | 21069454 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Mental retardation | 19951919 | CNVD |
Non-syndromic sensorineural hearing loss | 17873649 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Lung cancer | 16740712 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Developmental delay | 21147756 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Autism | 14699429 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:217264000-217271800 | Weak transcription | Pancreas | Pancrea |
2 | chr1:217264400-217270800 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
3 | chr1:217266200-217271200 | Weak transcription | Fetal Heart | heart |
4 | chr1:217266200-217271400 | Weak transcription | Fetal Intestine Small | intestine |
5 | chr1:217266200-217271800 | Weak transcription | Fetal Intestine Large | intestine |
6 | chr1:217269600-217270600 | Strong transcription | Breast Myoepithelial Primary Cells | Breast |
7 | chr1:217270400-217270600 | Enhancers | Fetal Muscle Leg | muscle |
8 | chr1:217270400-217271400 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
9 | chr1:217270600-217272200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
10 | chr1:217270600-217278200 | Weak transcription | Fetal Muscle Leg | muscle |
11 | chr1:217271000-217271400 | Enhancers | Adipose Nuclei | Adipose |
12 | chr1:217271400-217271600 | Enhancers | Fetal Heart | heart |
13 | chr1:217271400-217272000 | Enhancers | Sigmoid Colon | Sigmoid Colon |